BACKGROUND: Local ablation techniques are a major focus of current developments in oncology. The primary aim is to retain organs and preserve organ functions without compromising the oncological outcome. METHOD: Irreversible electroporation (IRE) is a novel ablation technique that involves the application of high-voltage pulses to induce cell apoptosis without causing thermal damage to the target tissue or adjacent structures. AIM: First published in 2005 IRE is currently undergoing preclinical and clinical trials in several areas of oncology and the initial results have been promising. The IRE technique could be a significant development in ablation treatment for renal cell carcinoma (RCC) but decisive proof of its effectiveness for local RCC has not yet been provided. This study presents the results of preclinical and initial clinical trials which are discussed and compared with those of other ablation techniques in order to demonstrate the current value of IRE.
BACKGROUND: Local ablation techniques are a major focus of current developments in oncology. The primary aim is to retain organs and preserve organ functions without compromising the oncological outcome. METHOD: Irreversible electroporation (IRE) is a novel ablation technique that involves the application of high-voltage pulses to induce cell apoptosis without causing thermal damage to the target tissue or adjacent structures. AIM: First published in 2005 IRE is currently undergoing preclinical and clinical trials in several areas of oncology and the initial results have been promising. The IRE technique could be a significant development in ablation treatment for renal cell carcinoma (RCC) but decisive proof of its effectiveness for local RCC has not yet been provided. This study presents the results of preclinical and initial clinical trials which are discussed and compared with those of other ablation techniques in order to demonstrate the current value of IRE.
Authors: David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman Journal: AJR Am J Roentgenol Date: 2002-01 Impact factor: 3.959
Authors: Johann Jakob Wendler; Maciej Pech; Simon Blaschke; Markus Porsch; Andreas Janitzky; Matthias Ulrich; Oliver Dudeck; Jens Ricke; Uwe-Bernd Liehr Journal: Cardiovasc Intervent Radiol Date: 2011-06-02 Impact factor: 2.740
Authors: Kathleen Kieran; Timothy L Hall; Jessica E Parsons; J Stuart Wolf; J Brian Fowlkes; Charles A Cain; William W Roberts Journal: J Urol Date: 2007-06-15 Impact factor: 7.450
Authors: Robert A Weersink; Jason Forbes; Stuart Bisland; John Trachtenberg; Mostafa Elhilali; Pierre H Brún; Brian C Wilson Journal: Photochem Photobiol Date: 2005 Jan-Feb Impact factor: 3.421
Authors: G Sersa; T Jarm; T Kotnik; A Coer; M Podkrajsek; M Sentjurc; D Miklavcic; M Kadivec; S Kranjc; A Secerov; M Cemazar Journal: Br J Cancer Date: 2008-01-08 Impact factor: 7.640
Authors: J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr Journal: Urologe A Date: 2015-06 Impact factor: 0.639